Abstract
We have examined the effects of Cyclosporin A (CsA) on growth and polyamine metabolism of MOLT-4, human T lymphoblastic leukaemia cells to ascertain the role of the polyamine biosynthetic pathway in the antitumour action of CsA. We observed that CsA had a dose-dependent inhibitory effect on growth of the cells in vitro, decreasing protein content, cell number and the rate of incorporation of 3H-thymidine into the cells. However, CsA treatment had no significant effect on intracellular polyamine levels in the cells. Contrary to previous reports, simultaneous addition of the diamine, putrescine, with CsA did not block or lessen the growth inhibitory effects of CsA. On the other hand, ornithine decarboxylase activity, the rate limiting enzyme of polyamine biosynthesis which converts ornithine to putrescine, was decreased by CsA treatment. This decrease appeared to be reversible and contrasts with the inhibition by alpha-difluoromethyl-ornithine, which is irreversible and can be overcome by addition of putrescine. This suppression of ornithine decarboxylase by CsA is more likely to occur by indirect effects on translation and/or transcription rather than a direct effect on the enzyme. It may be a contributory factor in the overall antiproliferative effects of CsA but is more likely to be a response to these growth inhibitory effects rather than a direct effect of the drug.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Borel J. F., Feurer C., Magnée C., Stähelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology. 1977 Jun;32(6):1017–1025. [PMC free article] [PubMed] [Google Scholar]
- Bowlin T. L., Rosenberger A. L., McKown B. J. Alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, augments cyclosporin A inhibition of cytolytic T lymphocyte induction. Clin Exp Immunol. 1989 Jul;77(1):151–156. [PMC free article] [PubMed] [Google Scholar]
- Fidelus R. K., Laughter A. H. Protein kinase activation and the immunosuppressant cyclosporine. Transplantation. 1986 Feb;41(2):187–192. [PubMed] [Google Scholar]
- Fischer G., Wittmann-Liebold B., Lang K., Kiefhaber T., Schmid F. X. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature. 1989 Feb 2;337(6206):476–478. doi: 10.1038/337476a0. [DOI] [PubMed] [Google Scholar]
- Foa P., Maiolo A. T., Baldini L., Quarto di Palo F., Starace G., Polli E. Cyclosporin A antileukemic activity: mode of action on target cells. Boll Ist Sieroter Milan. 1986;65(1):65–68. [PubMed] [Google Scholar]
- Foxwell B. M., Mackie A., Ling V., Ryffel B. Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein. Mol Pharmacol. 1989 Oct;36(4):543–546. [PubMed] [Google Scholar]
- Granelli-Piperno A., Andrus L., Steinman R. M. Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J Exp Med. 1986 Apr 1;163(4):922–937. doi: 10.1084/jem.163.4.922. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heby O. Role of polyamines in the control of cell proliferation and differentiation. Differentiation. 1981;19(1):1–20. doi: 10.1111/j.1432-0436.1981.tb01123.x. [DOI] [PubMed] [Google Scholar]
- Hess A. D., Tutschka P. J., Santos G. W. Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF. J Immunol. 1982 Jan;128(1):355–359. [PubMed] [Google Scholar]
- Kay J. E., Lindsay V. J. Polyamine synthesis during lymphocyte activation. Induction of ornithine decarboxylase and S-adenosyl methionine decarboxylase. Exp Cell Res. 1973 Mar 15;77(1):428–436. doi: 10.1016/0014-4827(73)90597-1. [DOI] [PubMed] [Google Scholar]
- Kingsnorth A. N., Lumsden A. B., Wallace H. M. Polyamines in colorectal cancer. Br J Surg. 1984 Oct;71(10):791–794. doi: 10.1002/bjs.1800711019. [DOI] [PubMed] [Google Scholar]
- Kingsnorth A. N., Wallace H. M., Bundred N. J., Dixon J. M. Polyamines in breast cancer. Br J Surg. 1984 May;71(5):352–356. doi: 10.1002/bjs.1800710513. [DOI] [PubMed] [Google Scholar]
- Klimpel G. R., Byus C. V., Russell D. H., Lucas D. O. Cyclic AMP-dependent protein kinase activation and the induction of ornithine decarboxylase during lymphocyte mitogenesis. J Immunol. 1979 Aug;123(2):817–824. [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- McLachlan G., Smart L. M., Wallace H. M., Thomson A. W. The potential of cyclosporin A as an anti-tumour agent. Int J Immunopharmacol. 1990;12(5):469–479. doi: 10.1016/0192-0561(90)90109-z. [DOI] [PubMed] [Google Scholar]
- Merker M. P., Merker M. M., Handschumacher R. E. Uptake and nature of the intracellular binding of cyclosporin A in a murine thymoma cell line, BW5147. J Immunol. 1984 Jun;132(6):3064–3070. [PubMed] [Google Scholar]
- Nooter K., Sonneveld P., Janssen A., Oostrum R., Boersma T., Herweijer H., Valerio D., Hagemeijer A., Baas F. Expression of the mdr3 gene in prolymphocytic leukemia: association with cyclosporin-A-induced increase in drug accumulation. Int J Cancer. 1990 Apr 15;45(4):626–631. doi: 10.1002/ijc.2910450409. [DOI] [PubMed] [Google Scholar]
- Quesniaux V. F., Schreier M. H., Wenger R. M., Hiestand P. C., Harding M. W., Van Regenmortel M. H. Molecular characteristics of cyclophilin-cyclosporine interaction. Transplantation. 1988 Aug;46(2 Suppl):23S–28S. doi: 10.1097/00007890-198808001-00005. [DOI] [PubMed] [Google Scholar]
- Russell D., Snyder S. H. Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc Natl Acad Sci U S A. 1968 Aug;60(4):1420–1427. doi: 10.1073/pnas.60.4.1420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ryffel B. Pharmacology of cyclosporine. VI. Cellular activation: regulation of intracellular events by cyclosporine. Pharmacol Rev. 1990 Sep;41(3):407–422. [PubMed] [Google Scholar]
- Saydjari R., Townsend C. M., Jr, Barranco S. C., Thompson J. C. Cyclosporine and alpha-difluoromethylornithine exhibit differential effects on colon and pancreatic cancer in vitro. Invest New Drugs. 1987;5(3):251–258. doi: 10.1007/BF00175295. [DOI] [PubMed] [Google Scholar]
- Sigal N. H., Siekierka J. J., Dumont F. J. Observations on the mechanism of action of FK-506. A pharmacologic probe of lymphocyte signal transduction. Biochem Pharmacol. 1990 Nov 15;40(10):2201–2208. doi: 10.1016/0006-2952(90)90712-t. [DOI] [PubMed] [Google Scholar]
- Smart L. M., MacLachlan G., Wallace H. M., Thomson A. W. Influence of cyclosporin A and alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on two rodent T-cell cancers in vivo. Int J Cancer. 1989 Dec 15;44(6):1069–1073. doi: 10.1002/ijc.2910440622. [DOI] [PubMed] [Google Scholar]
- Takahashi N., Hayano T., Suzuki M. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature. 1989 Feb 2;337(6206):473–475. doi: 10.1038/337473a0. [DOI] [PubMed] [Google Scholar]
- Thomson A. W., Forrest E. H., Smart L. M., Sewell H. F., Whiting P. H., Davidson R. J. Influence of cyclosporin A on growth of an acute T-cell leukaemia in PVG rats. Int J Cancer. 1988 Jun 15;41(6):873–879. doi: 10.1002/ijc.2910410618. [DOI] [PubMed] [Google Scholar]
- Thomson A. W., Moon D. K., Geczy C. L., Nelson D. S. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines. Immunology. 1983 Feb;48(2):291–299. [PMC free article] [PubMed] [Google Scholar]
- Twentyman P. R. A possible role for cyclosporins in cancer chemotherapy. Anticancer Res. 1988 Sep-Oct;8(5A):985–993. [PubMed] [Google Scholar]
- Tötterman T. H., Danersund A., Nilsson K., Killander A. Cyclosporin-A is selectively cytotoxic to human leukemic T cells in vitro. Blood. 1982 May;59(5):1103–1107. [PubMed] [Google Scholar]
- Wallace H. M., Gordon A. M., Keir H. M., Pearson C. K. Activation of ADP-ribosyltransferase in polyamine-depleted mammalian cells. Biochem J. 1984 Apr 1;219(1):211–221. doi: 10.1042/bj2190211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wallace H. M., Keir H. M. Uptake and excretion of polyamines from baby hamster kidney cells (BHK-21/C13). The effect of serum on confluent cell cultures. Biochim Biophys Acta. 1981 Aug 5;676(1):25–30. doi: 10.1016/0304-4165(81)90005-2. [DOI] [PubMed] [Google Scholar]
- Wallace H. M., Nuttall M. E., Robinson F. C. Acetylation of spermidine and methylglyoxal bis(guanylhydrazone) in baby-hamster kidney cells (BHK-21/C13). Biochem J. 1988 Jul 1;253(1):223–227. doi: 10.1042/bj2530223. [DOI] [PMC free article] [PubMed] [Google Scholar]
